What does Hubei Goto Biopharm Co.,Ltd. do?

Hubei Goto Biopharm Co.,Ltd. (300966.SZ) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 300966.SZ's market cap?

Hubei Goto Biopharm Co.,Ltd. (300966.SZ) has a market capitalization of approximately $2.80 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 300966.SZ pay a dividend?

Yes — Hubei Goto Biopharm Co.,Ltd. (300966.SZ) pays a dividend irregular, with a trailing-twelve-month yield of 0.19%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

Is 300966.SZ profitable?

Hubei Goto Biopharm Co.,Ltd. (300966.SZ) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

300966.SZ

Hubei Goto Biopharm Co.,Ltd.

SHZ·Biotechnology · Healthcare

¥24.32¥0.49−1.98%

Market cap¥2.80B·Market closed·Aug 26 7:04 AM UTC

Price Chart

¥24.32−¥0.49 (−1.98%)today

−48.02%CAGR −12.27%

Select date range

FromTo

Apr 9, 2021Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.19%

Annual Dividend (FWD)¥0.05

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend¥0.045

Ex-Dividend DateJul 16

Payment DateJul 16

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥628.90M

Net Income−¥71.24M

Net Margin−11.3%

Operating Cash Flow¥69.91M

Capital Expenditures¥110.12M

Free Cash Flow−¥40.21M

Return on Equity−8.6%

Return on Invested Capital0.0%

Net Debt¥1.14B

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 300966.SZ and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 300966.SZ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 300966.SZ and 80,000+ other tickers.

About Hubei Goto Biopharm Co.,Ltd.

Hubei Goto Biopharm Co.,Ltd. is a Chinese enterprise specializing in the manufacture and distribution of active pharmaceutical ingredients (APIs) and intermediate compounds for steroid hormones. Its product line features essential starting materials such as 9a-hydroxy-4-androstenedione (9a-OHAD), bisnoralcohol (BA), sitolactone, 1,4-androstadienedione (ADD), and 4-androstenedione (4-AD). The company also provides a variety of intermediates, including those for estrogens, progesterone, non-steroidal substances, various other hormones, and corticosteroids. Furthermore, Hubei Goto Biopharm…

CEO: Zubin Xi
Sector: Healthcare
Industry: Biotechnology
Exchange: SHZ
Employees: 893
Website: www.gotopharm.com

Peers

Peers Tab

000518.SZ

Jiangsu Sihuan Bioengineering Co., Ltd

Cap

¥4.0B

002873.SZ

Guiyang Xintian Pharmaceutical Co.,Ltd.

Cap

¥2.0B

002898.SZ

Sailong Pharmaceutical Group Co., Ltd.

Cap

¥65.1M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 300966.SZ

What does Hubei Goto Biopharm Co.,Ltd. do?: Hubei Goto Biopharm Co.,Ltd. (300966.SZ) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 300966.SZ's market cap?: Hubei Goto Biopharm Co.,Ltd. (300966.SZ) has a market capitalization of approximately $2.80 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 300966.SZ pay a dividend?: Yes — Hubei Goto Biopharm Co.,Ltd. (300966.SZ) pays a dividend irregular, with a trailing-twelve-month yield of 0.19%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.
Is 300966.SZ profitable?: Hubei Goto Biopharm Co.,Ltd. (300966.SZ) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.